Future therapies for cystic fibrosis

Lancet Respir Med. 2022 Aug;10(8):e75-e76. doi: 10.1016/S2213-2600(22)00253-3. Epub 2022 Jun 30.
No abstract available

Publication types

  • News

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Cystic Fibrosis Transmembrane Conductance Regulator / genetics
  • Cystic Fibrosis* / drug therapy
  • Humans
  • Mutation

Substances

  • Anti-Bacterial Agents
  • Cystic Fibrosis Transmembrane Conductance Regulator